A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia
S. Vadhan-Raj, R. Abonour, J. Goldman, David A. Smith, C. Slapak, R. Ilaria, R. Tiu, Xuejing Wang, S. Callies, J. Cox, J. Tuttle, Y. Lau, E. Roeland
Journal of Hematology & Oncology